These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3895662)

  • 1. Cyclosporine-associated renal dysfunction in marrow transplant recipients.
    Yee GC; Kennedy MS; Deeg HJ; Leonard TM; Thomas ED; Storb R
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):196-201. PubMed ID: 3895662
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute renal toxicity with combined use of amphotericin B and cyclosporine after marrow transplantation.
    Kennedy MS; Deeg HJ; Siegel M; Crowley JJ; Storb R; Thomas ED
    Transplantation; 1983 Mar; 35(3):211-5. PubMed ID: 6340275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the clinical, histopathologic, cytologic, and biochemical features of renal transplant rejection, cyclosporine A nephrotoxicity, and stable renal function.
    Taube D; Neild G; Hobby P; Holt D; Welsh K; Cameron JS
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):179-84. PubMed ID: 3895658
    [No Abstract]   [Full Text] [Related]  

  • 4. Profound hypomagnesemia and renal magnesium wasting associated with the use of cyclosporine for marrow transplantation.
    June CH; Thompson CB; Kennedy MS; Nims J; Thomas ED
    Transplantation; 1985 Jun; 39(6):620-4. PubMed ID: 3890292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of serum cyclosporine concentration with renal dysfunction in marrow transplant recipients.
    Kennedy MS; Yee GC; Mcguire TR; Leonard TM; Crowley JJ; Deeg HJ
    Transplantation; 1985 Sep; 40(3):249-53. PubMed ID: 3898489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months.
    Yee GC; McGuire TR; St Pierre BA; Self SG; Zager RA; Sullivan KM; Deeg HJ
    Bone Marrow Transplant; 1989 Nov; 4(6):691-4. PubMed ID: 2684309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that oral pentoxifylline reverses acute renal dysfunction in bone marrow transplant recipients receiving amphotericin B and cyclosporine. Results of a pilot study.
    Bianco JA; Almgren J; Kern DL; Ballard B; Roark K; Andrews F; Nemunaitis J; Shields T; Singer JW
    Transplantation; 1991 Apr; 51(4):925-7. PubMed ID: 2014558
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of two intravenous cyclosporine infusion schedules in marrow transplant recipients.
    Tallman MS; Nemunaitis JJ; McGuire TR; Yee GC; Hughes TE; Almgren JD; Appelbaum FR; Higano CS; McGuffin RW; Singer JW
    Transplantation; 1988 Apr; 45(4):810-3. PubMed ID: 3282363
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients.
    Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668
    [No Abstract]   [Full Text] [Related]  

  • 10. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.
    Storb R; Deeg HJ; Whitehead J; Appelbaum F; Beatty P; Bensinger W; Buckner CD; Clift R; Doney K; Farewell V
    N Engl J Med; 1986 Mar; 314(12):729-35. PubMed ID: 3513012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal function in patients with autoimmune diseases treated with cyclosporine.
    von Graffenried B; Harrison WB
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):215-31. PubMed ID: 3839609
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine-associated nephropathy in patients with heart and bone marrow transplants.
    Nizze H; Mihatsch MJ; Zollinger HU; Brocheriou C; Gokel JM; Henry K; Sloane JP; Stovin PG
    Clin Nephrol; 1988 Nov; 30(5):248-60. PubMed ID: 3063420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal function and blood pressure in heart transplant recipients treated with cyclosporine.
    Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C
    J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidiasis in the transplant patient.
    Clift RA
    Am J Med; 1984 Oct; 77(4D):34-8. PubMed ID: 6388324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertension and renal dysfunction in bone marrow transplant recipients.
    Kone BC; Whelton A; Santos G; Saral R; Watson AJ
    Q J Med; 1988 Dec; 69(260):985-95. PubMed ID: 3270085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized prospective trial comparing cyclosporine and methotrexate given for prophylaxis of graft-versus-host disease after bone marrow transplantation.
    Biggs JC; Atkinson K; Gillett E; Downs K; Concannon A; Dodds A
    Transplant Proc; 1986 Apr; 18(2):253-5. PubMed ID: 3515659
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical correlations of cyclosporine HPLC and FPIA levels in renal transplant recipients.
    Sridhar N; Schroeder TJ; Pesce AJ; First MR
    Transplant Proc; 1990 Jun; 22(3):1257-9. PubMed ID: 2190387
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of long-term cyclosporine immunosuppressive therapy on native kidneys versus renal allografts: serial renal function in heart and kidney transplant recipients.
    Lewis RM; Van Buren CT; Radovancevic B; Frazier OH; Janney RP; Powers PL; Golden DL; Giannakis JG; Macris MP; Kerman RH
    J Heart Lung Transplant; 1991; 10(1 Pt 1):63-70. PubMed ID: 2007172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine nephrotoxicity: exploration of the risk factors and prognosis of the renal injury.
    Keown PA; Stiller CR; Wallace AC; McKenzie FN; Wall W
    Transplant Proc; 1985 Aug; 17(4 Suppl 1):247-53. PubMed ID: 3895663
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring cyclosporin concentrations in marrow transplant recipients: comparison of two assay methods.
    Yee GC; Kennedy MS; Gmur DJ; Self SG; Deeg HJ
    Bone Marrow Transplant; 1987 Feb; 1(3):289-95. PubMed ID: 3332139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.